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Introduction
VP22 is one of the major tegumental components of herpes simplex virus type 1 (HSV-1) particles. It is composed of 361 amino acid residues encoded by UL49. 1 As a basic protein, VP22 is highly phosphorylated, and it has been identified in the nucleus of infected cells and in virions. 2, 3 Though its function is not well characterized, VP22 has been proposed to associate with the nuclear matrix during the replication cycle. 4 Viral mutants that overexpress VP22 increase the amount of VP22 in the tegument without affecting the viral growth cycle. 5 Interestingly, VP22 was recently reported to exit and re-enter cells through a cytoskeleton-mediated pathway. 6 Moreover, VP22 was found to mediate intercellular trafficking of a peptide and a 27-kDa green fluorescent protein (GFP) fused to the Cterminus of VP22 after endogenous expression. This intercellular trafficking was believed to be specific to the full-length protein since removal of the C-terminal 34 residues abolished this. 6 To investigate whether VP22 could mediate intercellular protein trafficking in human carcinoma cell lines and whether the C-terminal peptide would be sufficient for such a trafficking, we constructed plasmids expressing GFP 7 fused to either wild-type VP22 or C-terminal 160 residues of VP22. We report the expression and localization of the fusion proteins in cultured human and monkey cells.
Results
Construction of VP22-GFP fusion proteins Jellyfish GFP 7 was used as a marker to study the distribution of proteins fused to HSV-1 VP22. On the basis of the observation by Elliott and O'Hare 6 that the C-ter-
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Received 18 February 1998; accepted 18 May 1990 minal peptide is essential for intercellular protein trafficking, both wild-type VP22 (VP22w) and a peptide of 160 amino acid residues from the C-terminal of VP22 (VP22c) were fused with GFP. DNA fragments encoding VP22w or VP22c were cloned to the BamHI site of pEGFP-N1 (Clontech, Palo Alto, CA, USA) to generate plasmids expressing VP22c-GFP or VP22w-GFP fusion protein, respectively. The authenticity of DNA sequences for VP22w and VP22c and their fusion with GFP were verified by automatic DNA sequencing.
Characterization of gene expression in culture cells
To verify the production of GFP fusion proteins, H1299 and COS-1 cells transfected with pVP22c-GFP, pVP22w-GFP or pEGFP-N1 were harvested 3 days after transfection, lysed and subjected to SDS-PAGE. As expected, cells transfected with either pVP22c-GFP, pVP22w-GFP or pEGFP-N1 expressed the relevant protein ( Figure 1 ). The presence of wild-type GFP in the fusion constructs due to alternative translation was negligible.
Nuclear localization of fusion proteins
Expression of GFP fusion proteins in transfected cells was observed under a fluorescent microscope over time for up to 1 week after transfection. While GFP in pEGFP-N1-transfected cells was uniformly distributed, the fused GFPs in pVP22c-GFP-or pVP22w-GFP-transfected cells were mostly found in nuclei ( Figure 2) . In certain cells, fused GFPs were enriched around the nuclear rim. Cytoplasmic filament distribution was also noticed in some cells expressing fused GFPs but not always adjacent to nuclear-stained cells as reported. 6 Although the numbers of GFP-positive cells varied in all the transfected cells, the intracellular distributions of GFPs remained constant over time with a peak at 3-4 days after transfection. Similar distributions were observed in H1299, A549, COS-1 and COS-7 cells. Interestingly, GFP-containing particles were frequently observed in cells expressing fused GFPs, although more prominently in pVP22w-GFP-transfected cells than in pVP22c-GFP-transfected cells. Occasionally, some giant multiple-nucleus cells were observed in pVP22w-GFP or pVP22c-GFP-transfected cells. The significance of these observations was, however, not clear.
Unremarkable intercellular trafficking of VP22-GFP fusion proteins
To test the significance of intercellular trafficking of VP22/GFP fusion proteins, we evaluated the number of GFP-positive cells after plasmid transfection. COS-1 and H1299 cells (2 × 10 5 per well) were seeded into 24-well plates and cotransfected with 1 g of pEGFP-N1, pVP22c-GFP or pVP22w-GFP plus 1 g of a plasmid containing a lacZ-expressing cassette driven by the cytomegalovirus (CMV) early promoter. The cells were observed under a fluorescent microscope and then stained with X-gal 3 days after transfection. GFP-or ␤-gal-positive cells were scored randomly in seven fields per well under × 100 magnification (Table 1) . Overall, there was no significant difference in either the number of GFP-positive cells or the ratios of GFP-to ␤-gal-positive cells in the cell lines transfected with plasmids expressing either wild-type or fused GFPs. To investigate whether immunofluorescent staining of GFPs with an anti-GFP antibody would increase the sensitivity of detecting GFP-positive cells, H1299 cells transfected with pEGFP-N1, pVP22c-GFP or pVP22w-GFP were fixed and permeabilized 24 h after transfection. After incubation with a mouse anti-GFP monoclonal antibody (Clontech), the GFP-positive cells were then visualized with an anti-mouse IgG antibody labeled with fluorescein isothiocyanate (FITC) (PharMingen, San Diego, CA, USA). Intracellular GFP distributions detected by immunofluorescence assay were the same as those detected by life fluorescence. Except in a few cases where GFP fusion proteins were mainly found in the cytoplasm, most cells showed such proteins mainly in the nucleus (Figure 3 ). While immunofluorescence assay increased the sensitivity of detecting GFP-positive cells in general (data not shown), no apparent intercellular trafficking of GFPs to the neighboring cells was observed in cells transfected with all three GFP-expressing plasmids (Figure 3) .
Figure 2 Intracellular localization of GFP and VP22-GFP fusion proteins. Confluent monolayers of COS1 (a-c) and H1299 (d-f) cells as observed 4 days after transfection with pEGFP-N1 (a and d), pVP22w-GFP (b and e) and pVP22c-GFP (c and f). Note that within the monolayers, only GFPpositive cells are visible.
To test VP22-mediated intercellular protein trafficking further, H1299 cells expressing EGFP or VP22w-GFP were constructed by selecting the cells transfected with pEGFP-N1 or pVP22w-GFP in medium containing geneticin (800 g/ml). These GFP-expressing cells were then mixed with naive H1299 cells at a ratio of 1:10. A part of each mixture was then subjected to fluorescence-activated cell sorting (FACS) immediately after the mixing to determine the percentage of GFP-positive cells. A second part of each mixture was cultured at 37°C for another 24 h and then harvested for FACS analysis. The ratios of GFP-positive cells after 24 h of culture versus at 0 h were 1.31 ± 0.25 and 1.30 ± 0.44 for EGFP and VP22w-GFP transfectant cells, respectively. No significant difference was found between these two groups (P = 0.95). If significant intercellular trafficking of GFP proteins had occurred, either these ratios or the cell distribution revealed by flow cytometry analysis would have been changed after the culture of mixed cells, yet the cell distribution pattern in both groups remained the same as seen in the negative control (Figure 4 ).
Figure 4 FACS analysis of mixed cultures of naive H1299 cells, pEGFP-N1 transfectants and pVP22w-GFP transfectants. (a) Naive H1299 cells alone, (b) naive H1299 cells plus pEGFP-N1 transfectant and (c) naive H1299 cells plus pVP22w-GFP transfectants. The solid line indicates 0 h, and the dotted line indicates 24 h after the start of mixed culture.

Discussion
Our study was designed to see whether VP22 could mediate intercellular trafficking of proteins in human cancer and monkey cells and whether a C-terminal portion of VP22 would be sufficient for such trafficking. The results of our study suggest that the use of VP22 for mediating intercellular trafficking of transgene product is limited.
Intercellular trafficking of proteins is attractive in the field of gene therapy because, by increasing the numbers of transgene product-positive cells, it can create or increase the bystander effects of a therapeutic gene. Intercellular trafficking of certain secretory proteins is already well known. Lysosomal enzymes, for example, are secreted from and re-enter cells by mannose-6-phosphate-mediated pathways. 8 With few exceptions 9, 10 secretory proteins are translocated across the endoplasmic reticulum (ER) membrane during their synthesis. Such translocation is mediated by a hydrophobic signal sequence, a signal recognition protein (SRP), and an SRP receptor (docking protein) located in the ER. [11] [12] [13] Secretory proteins are then packaged into vesicles in the Golgi apparatus and exit cells via membrane fusion, 14 a process that can be partially suppressed by microtubule inhibitors. 15 Re-entry into the cells is mostly accomplished by receptor-dependent endocytosis, although other mechanisms have been reported. 16, 17 HSV-1 VP22 can reportedly exit cells in which it is synthesized via a Golgi-independent mechanism and reenter surrounding cells with high efficiency. 6 Moreover, VP22 can mediate intercellular trafficking of the 27-kDa GFP when the two are fused. VP22 is, therefore, attractive for gene therapy because it might be used to create or enhance bystander effects by increasing the intercellular trafficking of transgene products into adjacent untransduced cells. In this study, however, we observed most of the intracellular distribution patterns of VP22-GFP fusion protein reported by Elliott and O'Hare but not the dramatic increase in the number of GFP-positive cells that they saw. Although our results do not preclude the intercellular trafficking of VP22-GFP fusion proteins, this lack of a dramatic increase in the number of GFP-positive cells indicates that such trafficking will be of little or no use in gene therapy. Moreover, since the entire VP22 coding sequence used in our constructs has been confirmed by sequencing, the discrepancy between our results and those of Elliott and O'Hare 6 should not be attributed to VP22 sequence variance. In fact, the primer used for constructing VP22-EGFP fusion constructs was designed in such a way that the junction site of VP22 and EGFP remained the same as reported. 6 Intercellular trafficking of VP22 itself, however, was not examined in this study.
Our study also found that the 160 amino acid peptide from the VP22 C-terminus is sufficient to mediate nuclear localization, a distribution pattern reportedly due to intercellular trafficking. 6 Even though it lacks a classical nuclear localization sequence, 18 VP22 has long been known to be localized in the nucleus of infected cells. 2, 3 The high amount of positively charged amino acid residues in VP22 may account for this. The positively charged amino acid arginine, for example, accounts for 10.8% of the amino acids in VP22 and for 12.2% of the amino acids in the C-terminal 160-residue peptide. However, the functional significance of VP22's nuclear localization has yet to be analyzed.
Materials and methods
Plasmid construction HSV-1 type 1 genomic DNA was kindly provided by Dr R Mitchell (Baylor College of Medicine, Houston, TX, USA). The DNA fragment encoding VP22c was cloned by polymerase chain reaction (PCR) using the following primers: (1) 5Ј-GGATCCACCATGGGCAGGAAATCGG CCC-3Ј and (2) 5Ј-GCTCGAGATTACGGATCCTCGACG GGCCGTCTGG-3Ј. The primers were designed to place an ATG start codon at the 5Ј end and a BamHI site before the stop codon, as described previously. 5 The DNA fragment encoding VP22w was cloned from HSV-1 genomic DNA directly (detailed cloning steps are available upon request). To introduce a BamHI site before the stop codon in VP22w, a 0.28-kb SphI-XbaI fragment from VP22c replaced that in VP22w.
Cell culture and transfection
Human lung carcinoma cell lines A549 and H1299 and monkey kidney cell line COS-1 were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 4.5 g/l glucose, 10% FBS, 100 U/ml penicillin, and 100 g/ml streptomycin. For in vitro transfection with plasmids, cells were seeded at 5 × 10 5 per well of six-well plates. Plasmid DNA was transfected into cultured cells by calcium phosphate methods as described previously. 19 Western blot analysis Cell lysates were prepared by lysing monolayer cells in six-well plates with 0.1 ml of 125 mm Tris-pH 6.8, 2% SDS, 10% glycerol. For Western blot analysis, 20 g of proteins from each whole cell lysate were loaded on to a 12% SDS-polyacrylamide gel and separated by electrophoresis. The proteins were electrotransferred on to a Hybond-ECL membrane (Amersham, Arlington Heights, IL, USA), which was then blocked with 5% dry milk and 0.3% Tween 20 in phosphate-buffered saline (PBS). Next, the membrane was probed with anti-GFP polyclonal antibody (Clontech) and mouse anti-human ␤-actin monoclonal antibody (Amersham), followed by incubation with biotinylated anti-rabbit and anti-mouse immunoglobulins. Finally, the membrane was washed and incubated with horseradish peroxidase-conjugated streptavidin (DAKO, Carpinteria, CA, USA). Specific binding was detected using an Enhanced Chemiluminescence Kit (Amersham).
Biochemical analysis
Protein concentrations were determined using a kit from GIBCO BRL (Gaithersburg, MD, USA) according to the manufacturer's instructions. Bacterial ␤-galactosidase was detected by histochemical staining with X-gal as described previously. 20 Automatic DNA sequencing was performed at the DNA Core Sequencing Facility at the University of Texas MD Anderson Cancer Center.
Immunofluorescence analysis
Immunofluorescence analysis for GFP-positive cells was performed as described. 1 In brief, cells were washed with PBS, fixed and permeabilized for 15 min at room temperature with 100% methanol. The samples were then blocked with 10% calf serum in PBS for 15 min at room temperature. Mouse anti-GFP monoclonal antibody was added to the same solution at a concentration of 1:500, as recommended by the manufacturer (Clontech). The samples were then incubated at room temperature for 20 min, washed twice with PBS, and incubated for another 10 min with blocking solution containing an anti-mouse IgG antibody labeled with FITC (PharMingen). Samples were then washed with PBS and observed under a microscope.
Fluorescence-activated cell sorting (FACS)
FACS analysis was performed as described previously. 21 In brief, cells were harvested into cell culture medium by the trypsin-EDTA treatment. Cells were then collected after brief centrifugation and resuspended in PBS containing 5% fetal bovine serum and 0.1 mm EDTA. Cells were sorted by 488 nm excitation in the FACS core facility at our institution.
Statistical analysis
Differences between each group of cells were assessed by ANOVA using STATISTICA software from StatSoft (Tulsa, OK, USA). P values of Ͻ0.05 or less were considered significant.
